ERIN MCCORMICK-KELLY: Open Payments
NPI 1033860903 · MOUNT LAUREL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 44 payments from 8 companies in 2025. Trend: 2023 $798 · 2024 $463 · 2025 $1,036
Food & beverage: $1,036
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $323 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $183 |
| Ardelyx, Inc. | 8 | $141 |
| GENZYME CORPORATION | 2 | $124 |
| Lilly USA, LLC | 1 | $107 |
| Regeneron Healthcare Solutions, Inc. | 5 | $87 |
| One Lambda, Inc. | 1 | $58 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: DUPIXENT, XIFAXAN, IBSRELA, ZEPBOUND, LINZESS, SKYRIZI, RINVOQ, VOQUEZNA.
Industry payments across NJ — which companies pay providers there.
